We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Multi-Site Trials and New Technology Need Better Regulation
FDA: Multi-Site Trials and New Technology Need Better Regulation
May 24, 2006
The FDA intends to improve supervision of multi-site clinical trials by working on a guidance on the use of coordinators who are not principal investigators (PI), an FDA official has announced.